Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-02-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole filed by Mylan Pharmaceuticals (ANDA 090763).
-
FDA approval · 2024-02-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium submitted by Zydus Pharmaceuticals USA Inc., enabling the generic esomepr…
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: Helicobacter Pylori Eradication Therapy for Epileptic Children [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating Helicobacter pylori eradication therapy as a treatment approach for epilepsy in children.
-
FDA approval · 2024-01-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Biocon Pharma Inc.,)
The FDA approved Biocon Pharma Inc.'s supplemental application for Esomeprazole Magnesium, a generic esomeprazole product, under ANDA 213486…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori [Phase 3]
A Phase 3 clinical trial compared tegoprazan to esomeprazole-containing bismuth quadruple therapy for Helicobacter pylori eradication, repor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants [Phase 2]
Phase 2 trial results on efficacy and safety after multiple doses of TNP-2198 capsules, rabeprazole enteric-coated tablets, and amoxicillin …
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Fucoidan Assisted Eradication of Helicobacter Pylori [Phase 1, Phase 2]
An early-phase clinical trial investigating fucoidan as an aid to eradicate Helicobacter pylori infection, with phases 1 and 2 ongoing and c…
-
EMA approval · 2023-12-04EMA Authorised: Pylobactell (urea (13C)) — Richen Europe S.R.L
Pylobactell, a urea-13C breath test product, has been authorised in Europe for use in breath testing and Helicobacter pylori infection asses…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules [Phase 1, Phase 2]
Phase 1/2 trial evaluating preliminary eradication of Helicobacter pylori using TNP-2198 with rabeprazole and comparisons to rabeprazole plu…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Bismuth Quadruple Therapy Versus Standard Triple Therapy [Phase 4]
Phase 4 clinical trial comparing Bismuth Quadruple Therapy to Standard Triple Therapy for Helicobacter pylori infection.
-
FDA approval · 2023-11-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for esomeprazole magnesium from Sun Pharmaceutical Industries, Inc. under an ANDA process, indicatin…
-
FDA approval · 2023-11-14FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' generic esomeprazole magnesium. This action confirms regulatory appr…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD [Phase 3]
A Phase 3 trial evaluating whether eradication of Helicobacter pylori affects gastric preneoplastic lesions and neoplasia after endoscopic s…
-
FDA approval · 2023-11-08FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium from Zydus Pharmaceuticals USA Inc., supporting its generic approval.
-
FDA approval · 2023-11-01FDA Approved: VOQUEZNA — Original Application (Phathom Pharmaceuticals Inc.)
FDA approves Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals as an original application for the treatment of Helicobacter pylori…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection [Phase 3]
A Phase 3 trial update evaluating optimization of vonoprazan–amoxicillin dual therapy for Helicobacter pylori eradication has completed.
-
FDA approval · 2023-10-31FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Rabeprazole sodium submitted by Ascend Laboratories, LLC. This action approves the referenced ge…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies [Phase 3]
Phase 3 trial comparing hybrid, high-dose dual, and bismuth quadruple therapies for Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication [Phase 3]
Phase 3 trial update on potassium competitive acid blockers for Helicobacter pylori eradication has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT [Phase 4]
A Phase 4 randomized trial comparing amoxicillin-esomeprazole high-dose dual therapy to levofloxacin triple therapy for Helicobacter pylori …
-
FDA approval · 2023-10-11FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting regulatory approval for changes to the generic product'…
-
FDA approval · 2023-10-11FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a Supplemental Application for omeprazole by Sandoz Inc, confirming approval of a supplement to the Abbreviated New Drug Applic…
-
FDA approval · 2023-10-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium from Mylan Pharmaceuticals, making a generic version of the proton pump i…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Levofloxacin Concomitant Versus Levofloxacin Sequential [Phase 4]
A Phase 4 clinical trial comparing concomitant versus sequential levofloxacin regimens for Helicobacter pylori infection; recruitment has no…
-
FDA approval · 2023-09-29FDA Approved: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG — Original Application (MARKSANS PHARMA LIMITED)
FDA approved Marksans Pharma Limited's esomeprazole magnesium delayed-release capsules, 20 mg, as a generic therapeutic option for common ac…